GR-113808 is a drug which acts as a potent and selective 5-HT4serotoninreceptorantagonist. It is used in researching the roles of 5-HT4 receptors in various processes, and has been used to test some of the proposed therapeutic effects of selective 5-HT4 agonists, such as for instance blocking the nootropic effects of 5-HT4 agonists, and worsening the respiratory depression produced by opioid analgesic drugs, which appears to be partly 5-HT4 mediated and can be counteracted by certain 5-HT4 agonists.
^Mikami T, Sugimoto H, Naganeo R, Ohmi T, Saito T, Eda H (July 2008). "Contribution of active and inactive states of the human 5-HT4d receptor to the functional activities of 5-HT4-receptor agonists". Journal of Pharmacological Sciences. 107 (3): 251–9. doi:10.1254/jphs.fp0072230. PMID18587219.
^Matsuyoshi H, Kuniyasu H, Okumura M, Misawa H, Katsui R, Zhang GX, Obata K, Takaki M (July 2010). "A 5-HT(4)-receptor activation-induced neural plasticity enhances in vivo reconstructs of enteric nerve circuit insult". Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 22 (7): 806–13, e226. doi:10.1111/j.1365-2982.2010.01474.x. PMID20146727.